上海市2016—2019年抗结核药物使用情况分析与评价

Analysis and evaluation of the use of anti-tuberculosis drugs in Shanghai from 2016 to 2019

目的:分析上海市2016—2019年抗结核药物使用情况。方法:根据销售金额、用药频度和限定日费用,对上海市2016—2019年抗结核药物的使用情况进行统计,并分析抗结核药物的用药特点及变化趋势。结果与结论:上海市2016—2019年抗结核药物的销售金额逐年增加,2019年较2016年增加42.64%。在抗结核药物用药频度排序中,异烟肼、乙胺丁醇、利福平和吡嗪酰胺一直居前4位。

Objective:To analyze the application status of anti-tuberculosis drugs in Shanghai from 2016 to 2019.Methods:According to the sales,defined daily dose system(DDDs),defined daily cost,their application in Shanghai from 2016 to 2019 was statistically analyzed and their characteristics and changing trend were also analyzed.Results&Conclusion:The sales of anti-tuberculosis drugs in Shanghai from 2016 to 2019 increased year by year,with an increase of 42.64%in 2019 compared with 2016,in which ethambutol,pyrazinamide,isoniazid and rifampicin ranked the top four in the list of DDDs.